Lisinopril vs Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer
J Am Coll Cardiol 2019 Jun 11;73(22)2859-2868, M Guglin, J Krischer, R Tamura, A Fink, L Bello-Matricaria, W McCaskill-Stevens, PN MunsterFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.